What is the 13F Pro Quality Score for SINT?

13F Pro ranks Sintx Technologies, Inc. (SINT) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View SINT's current score at https://13fpro.ai/company/SINT (free sign-up required for the full ranking).

Which hedge funds own the most SINT stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of SINT include Bleichroeder, Stonepine Capital Management,, Veracity Capital. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/SINT as soon as new 13F filings post.

Where does 13F Pro source SINT data?

All Sintx Technologies, Inc. fundamentals and ownership data come directly from SEC EDGAR. Sintx Technologies, Inc. files with the SEC under CIK 1269026. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is SINT in?

Sintx Technologies, Inc. (SINT) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is SINT research updated on 13F Pro?

SINT's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Sintx Technologies, Inc.(SINT)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1269026 SINT stock profile & AI dashboard →

13F Pro Quality Score

14.5/100

Rank #2,863 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why SINT Scores 15/100

exact factor attribution · 2026-09-11

SINT's composite is driven by institutional flow and earnings growth, held back by revenue growth and scale. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Institutional flow

+2.2 pts

94th pct

Earnings growth

+2.1 pts

92th pct

Shareholder dilution

-2.3 pts

5th pct

Earnings quality

-3.1 pts

19th pct

Capital efficiency

-4.7 pts

4th pct

Profitability

-6.6 pts

6th pct

Free cash flow

-6.7 pts

5th pct

Scale

-7.1 pts

3th pct

Revenue growth

-9.4 pts

3th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

SINT Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Sintx Technologies, Inc. (SINT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SINT at 14.5/100 on a 32-signal composite quality model, placing it at rank #2,863 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Sintx Technologies, Inc. reports quarterly revenue of $452.0K, net income of $-2.7M, free cash flow of $-2.9M. Top institutional holders of SINT by reported 13-F value include Bleichroeder, Stonepine Capital Management, Veracity Capital, based on the most recent SEC filings. SINT trades on the Nasdaq exchange and files with the SEC under CIK 1269026. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SINT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Sintx Technologies, Inc. directly from SEC EDGAR. Sintx Technologies, Inc.'s 13F Pro composite quality score has ranged between 5 and 15 since 2026, currently 14.5 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.

Revenue

Q2 2026

$452.0K

Net Income

Q2 2026

$-2.7M

Free Cash Flow

Q2 2026

$-2.9M

D/E Ratio

Q2 2026

0.02

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-64.7% YoY

$1.0MFY 2025

FY22 $1.6MFY23 $2.6MFY24 $2.9MFY25 $1.0M

Net Income

+6.0% YoY

$-10.4MFY 2025

FY22 $-12.0MFY23 $-8.3MFY24 $-11.0MFY25 $-10.4M

Operating Income

+23.7% YoY

$-10.7MFY 2025

FY22 $-11.3MFY23 $-13.4MFY24 $-14.0MFY25 $-10.7M

EPS (Diluted)

+18.9% YoY

$-6.16FY 2025

FY22 $-30.41FY23 $-312.24FY24 $-7.59FY25 $-6.16

Total Assets

+1.0% YoY

$9.5MFY 2025

FY22 $15.8MFY23 $15.4MFY24 $9.4MFY25 $9.5M

Total Debt

-78.1% YoY

$7.0KFY 2025

FY22 $528.0KFY23 $46.0KFY24 $32.0KFY25 $7.0K

Op. Cash Flow

+0.8% YoY

$-8.6MFY 2025

FY22 $-10.3MFY23 $-14.1MFY24 $-8.6MFY25 $-8.6M

Free Cash Flow

+6.2% YoY

$-8.8MFY 2025

FY22 $-11.7MFY23 $-14.6MFY24 $-9.3MFY25 $-8.8M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$1.0M -64.7%	$2.9M +9.9%	$2.6M +68.3%	$1.6M +157.6%	$606.0K +2.0%	$594.0K
Net Income	$-10.4M +6.0%	$-11.0M -33.5%	$-8.3M +31.4%	$-12.0M -29.3%	$-9.3M -32.4%	$-7.0M
Operating Income	$-10.7M +23.7%	$-14.0M -5.2%	$-13.4M -17.8%	$-11.3M -6.7%	$-10.6M -24.9%	$-8.5M
EPS (Diluted)	$-6.16 +18.9%	$-7.59 +97.6%	$-312.24 -926.9%	$-30.41 -52.4%	$-19.95 -1747.7%	$-1.08
Total Assets	$9.5M +1.0%	$9.4M -38.7%	$15.4M -2.6%	$15.8M -27.8%	$21.8M -28.3%	$30.4M
Total Debt	$7.0K -78.1%	$32.0K -30.4%	$46.0K -91.3%	$528.0K -48.1%	$1.0M +157.1%	$396.0K
Operating Cash Flow	$-8.6M +0.8%	$-8.6M +38.8%	$-14.1M -37.5%	$-10.3M -1.3%	$-10.1M -11.1%	$-9.1M
Free Cash Flow	$-8.8M +6.2%	$-9.3M +36.3%	$-14.6M -25.5%	$-11.7M +15.9%	$-13.9M -46.4%	$-9.5M

Get alerted when SINT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Sintx Technologies, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of SINT

Bleichroeder LP
$978.0K523,013 sh
Stonepine Capital Management, LLC
$558.4K627,615 sh
Veracity Capital LLC
$143.4K76,674 sh
CITADEL ADVISORS LLC
$59.7K31,930 sh
GEODE CAPITAL MANAGEMENT, LLC
$56.3K30,101 sh
VANGUARD FIDUCIARY TRUST CO
$44.0K23,531 sh
VANGUARD CAPITAL MANAGEMENT LLC
$39.1K20,905 sh
STATE STREET CORP
$24.9K13,302 sh
HRT FINANCIAL LP
$23.0K12,831 sh
UBS Group AG
$22.3K11,921 sh

Fund	Value	Shares
Bleichroeder LP	$978.0K	523,013
Stonepine Capital Management, LLC	$558.4K	627,615
Veracity Capital LLC	$143.4K	76,674
CITADEL ADVISORS LLC	$59.7K	31,930
GEODE CAPITAL MANAGEMENT, LLC	$56.3K	30,101
VANGUARD FIDUCIARY TRUST CO	$44.0K	23,531
VANGUARD CAPITAL MANAGEMENT LLC	$39.1K	20,905
STATE STREET CORP	$24.9K	13,302
HRT FINANCIAL LP	$23.0K	12,831
UBS Group AG	$22.3K	11,921

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put SINT on your watchlist

Track score changes the day Sintx Technologies, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is SINT a good stock to buy?

13F Pro's AI-powered analysis of Sintx Technologies, Inc. (SINT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SINT are available on the SINT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. SINT is classified as a small company.

Which hedge funds own SINT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SINT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Sintx Technologies, Inc.'s investment landscape.